A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Hims adds Grail's cancer test amid questions about widespread use
Hims adds Grail's cancer test amid questions about widespread use
Novartis says generics to erode $4B from 2026 sales
Novartis says generics to erode $4B from 2026 sales
Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
FDA seeks withdrawal of Amgen's Tavneos, company says it won't pull drug
FDA seeks withdrawal of Amgen's Tavneos, company says it won't pull drug
UK’s health department expected to spend £1B in pharma trade deal with US
UK’s health department expected to spend £1B in pharma trade deal with US
Novo expects sales to fall in 2026, triggering selloff
Novo expects sales to fall in 2026, triggering selloff
'Turning around the Titanic': How the incoming PBM reforms will transform CMS
'Turning around the Titanic': How the incoming PBM reforms will transform CMS
What's driving health tech M&A
What's driving health tech M&A
China startup AccurEdit raises $75M for gene editing therapies
China startup AccurEdit raises $75M for gene editing therapies
Daiichi ends work on an ADC; Layoffs at GSK's R&D unit
Daiichi ends work on an ADC; Layoffs at GSK's R&D unit
Ultragenyx unwraps data that may be central to its gene therapy resubmission
Ultragenyx unwraps data that may be central to its gene therapy resubmission
Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
AstraZeneca gets CRL for prefilled pen version of lupus drug Saphnelo
AstraZeneca gets CRL for prefilled pen version of lupus drug Saphnelo
Carbon Health files for bankruptcy, seeking to sell or restructure
Carbon Health files for bankruptcy, seeking to sell or restructure
First 10 Medicare-negotiated drug prices have taken effect: Are seniors really saving money?
First 10 Medicare-negotiated drug prices have taken effect: Are seniors really saving money?
New CagriSema data show improvement over semaglutide
New CagriSema data show improvement over semaglutide
GSK returns rights to Wave's RNA editing program for AATD
GSK returns rights to Wave's RNA editing program for AATD
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page